3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
7
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Fallopian Tube Neoplasms
4
Adenocarcinoma Of Esophagus
4
Squamous Cell Carcinoma of Head and Neck
3
Pancreatic Neoplasms
3
Melanoma
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Triple Negative Breast Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Anatomic Stage I Breast Cancer AJCC v8
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Laryngeal Neoplasms
1
Interventions
Cyclophosphamide
10
fludarabine
7
pomalidomide
5
pembrolizumab
5
Dexamethasone
5
daratumumab
4
obinutuzumab
3
glofitamab
3
fludarabine phosphate
3
abemaciclib
3
Rituximab
3
Melphalan
3
Immunotherapy, Adoptive
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
pirtobrutinib
2
palbociclib
2
cemiplimab
2
blinatumomab
2
Temozolomide
2
Sirolimus
2
Oxaliplatin
2
Nivolumab
2
Mesna
2
Letrozole
2
Injections
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Taxes
×
30 days
×
Clear all
No trials found.